MedTrace Logo

A Study Evaluating the Clinical Performance of the ViaValve™ Safety IV Catheter

NCT02119351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2014-04-21

No results posted yet for this study

Summary

The objective of this post-market, prospective study is to evaluate the clinical acceptability, blood leakage, risk for blood exposure, need for digital compression, insertion success, and clinical utility of the ViaValve™ Safety IV Catheter compared to standard hospital PIVCs currently being used.

Conditions

  • Peripheral Intravenous Catheter

Interventions

DEVICE

ViaValve™ Safety IV Catheter

Safety peripheral IV catheter with a blood control feature

DEVICE

ProtectIV® Plus Safety IV Catheter

Safety peripheral IV catheter with no blood control feature

Sponsors & Collaborators

  • Smiths Medical, ASD, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew McRae, MD, PhD · U of Calgary and Alberta Health Services

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02119351 on ClinicalTrials.gov